Cite
HARVARD Citation
Selim, M. et al. (2019). Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet neurology. 18 (5), pp. 428-438. [Online].